Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases

Autoimmunity Reviews · Published 2026-05-25 · DOI 10.1016/j.autrev.2026.104098

Authors (4)

Jun Diao, Hui Cao, Jing Zhou, Jian Shen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Diao, J., Cao, H., Zhou, J., et al. (2026). Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2026.104098

Related articles

• Rewiring immunometabolism in hepato-biliary-pancreatic cancers: Unraveling TME-mediated metabolic suppression and advancing next-generation immunotherapeutic approaches · Autoimmunity Reviews · 2026 · Same journal
• Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis · Autoimmunity Reviews · 2026 · Same journal
• The future of TCR-Treg therapies is renewables · Autoimmunity Reviews · 2026 · Same journal
• Inflammatory biomarkers of atherosclerosis in SLE that may improve SLE-specific cardiovascular risk assessment tools · Autoimmunity Reviews · 2026 · Same journal
• Iron, autoimmunity, and thrombosis: Exploring sex-specific interactions · Autoimmunity Reviews · 2026 · Same journal
• The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation · Autoimmunity Reviews · 2026 · Same journal
• Fatty acid oxidation and inflammatory bowel disease: Highlighting the roles of pathogenesis and treatment · Autoimmunity Reviews · 2026 · Same journal
• Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link? · Autoimmunity Reviews · 2026 · Same journal
• The role of myeloid-derived suppressor cells in Sjögren's disease · Autoimmunity Reviews · 2026 · Same journal
• ANCA-associated vasculitis: From immunopathogenesis to diagnosis and toward precision therapy · Autoimmunity Reviews · 2026 · Same journal